Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
80 participants
INTERVENTIONAL
2009-01-31
2009-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Statement of Care of Anemia in Delivering Patients at Nord Franche-Comte Hospital
NCT04812821
Iron Metabolism Parameters At First Trimester and preGnancy outcomE
NCT03176147
Prevalence Study of the Etiology of Pregnancy Anemia
NCT03448432
Questionnaire About Risk Factors of Iron Deficiency Anemia in Pregnancy
NCT06761352
The Efficacy of Intermittent Versus Daily Oral Iron Supplementation in Anaemic Pregnant Women.
NCT05278793
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The other part of the patients will have a NFS and at the first quater of the pregnancy.
All the patient will have a NFS at the results of the sixth month of the pregnancy.
A NFS will be done during the results at the end of the pregnancy like we do now.
Then a NFS at 48 hours after the birth. A treatment with iron will be done and according to the results
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
NFS and iron in the first quater
first arm: dosage NFS and iron during the beginning of the pregnancy then in the sixth month of pregnancy then in th delivery.
dosage of the NFS and iron
a blood test will be made.
No NFS and iron in the first quater
second arm: dosage NFS and iron during the sixth month of pregnancy then in th delivery. No dosage of NFS and iron during the beginning of the pregnancy
dosage of the NFS and iron
a blood test will be made.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
dosage of the NFS and iron
a blood test will be made.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* pregnancy women affected by béta thalassemia
* pregnancy woman having had a périconceptionnel treatment against the anaemia
18 Years
55 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Limoges
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Vincelot anne, MD
Role: PRINCIPAL_INVESTIGATOR
Limoges UH
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU limoges
Limoges, Limousin, France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
I08009
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.